9
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Attenuation of Reserpine-Induced Catalepsy by Melatonin and the Role of the Opioid System

&
Pages 297-301 | Received 28 Jun 1989, Published online: 07 Jul 2009

References

  • Agid Y., Javoy‐Agid F. Peptides and Parkinson's disease. Trends in Neurosciences 1985; 8: 30–35
  • Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional serotonin metabolism. International Journal of Neuroscience 1985; 26: 9–13
  • Anton‐Tay F., Diaz J. L., Fernandez‐Guardiola A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sciences 1971; 10: 841–850
  • Anton‐Tay F., Chou C., Anton S., Wurtman R. J. Brain serotonin concentrations: Elevation following intraperitoneal administration of melatonin. Science 1968; 162: 277–279
  • Burke R. E. Tardive dyskinesia: Current clinical issues. Neurology 1984; 34: 1348–1353
  • Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movements induced by L‐dopa in mice. Science 1971; 173: 450–452
  • Creese Z. I., Sibley D. R., Hamblin M. W., Leff S. E. The classification of dopamine receptors: relationship to radioligand binding. Annual Review of Neuroscience 1983; 6: 43–71
  • Erlich S. S., Apuzzo L. J. The pineal gland: Anatomy, physiology and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
  • Fuenmayer L. D., Bermundez M. Effect of the cerebral tryptaminergic system on the turnover of dopamine in the striatum of the rat. Journal of Neurochemistry 1985; 44: 670–674
  • Jaffe J. H., Martin W. R. Opioid analgesics and antagonists. The pharmacological basis of therapeutics7th Ed., A. G. Gilman, L. S. Goodman, T. W. Rall, F. Murad. Macmillan Publishers, New York 1985; 491–531
  • Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neurosciene Letters 1985; 19: 237–242
  • Lakin M. L., Miller C. H., Stratt M. L., Winters W. D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sciences 1981; 29: 2543–2551
  • Lissoni P., Espositi P., Espositi G., Mauri R., Resentini M., Morabito F., Fumagalli P., Santagostino A., Delitala G., Fraschini F. A clinical study on the relationship between the pineal gland and the opioid system. Journal of Neural Transmission 1986; 65: 63–73
  • Lowenstein P., Pereyra E. N., Solveyra C. G., Cardinalli D. Effect of naloxone on the nocturnal rise of rat pineal melatonin content. European Journal of Pharmacology 1984; 98: 261–264
  • Nappi G., Petraglia F., Martignoni E., Facchinetti F., Bono G., Genazzani A. R. Beta‐endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology 1985; 35: 1371–1374
  • Park M. R., Gonzales‐Vegas J. A., Kitai S. T. Serotonergic excitation from dorsal raphe stimulation recorded intracellularly from rat caudate putamen. Brain Research 1982; 243: 49–58
  • Sandyk R. The endogenous opioid peptides in neurological disorders of the basal ganglia. Life Sciences 1985; 37: 1655–1663
  • Sandyk R. Neuroleptic‐opioid interaction: Relevance to tardive dyskinesia. International Journal of Neuroscience 1986; 30: 33–36
  • Sandyk R., Fisher H. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. Journal of Clinical Psychopharmacology 1989; 9: 147–148
  • Sandyk R., Fisher H. Melatonin potentiates the effects of naloxone on reserpine‐induced catalepsy in the rat. International Journal of Neuroscience
  • Shaw K. M., Stern G. M., Sandier M. Melatonin and parkinsonism. Lancet 1973; i: 271
  • Sugden D., Morris R. D. Changes in regional brain levels of tryptophan, 5‐HTP and 5‐HIAA, dopamine and noradrenaline after pinealectomy in the rat. Journal of Neurochemistry 1979; 32: 1593–1594
  • Sugden D. Psychopharmacological effects of melatonin in mouse and rat. Journal of Pharmacology and Experimental Therapeutics 1983; 227: 587–591
  • Yurek D. M., Randall P. K. Simultaneous catalepsy and apomorphine‐induced stereotypic behavior in mice. Life Sciences 1985; 37: 1665–1673

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.